Detailed price information for Entrada Therapeutics Inc (TRDA-Q) from The Globe and Mail including charting and trades.
Entrada Therapeutics (TRDA) delivered earnings and revenue surprises of +12.93% and +2.05%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Detailed price information for SpaceX Corp (SPCX-Q) from The Globe and Mail including charting and trades.
Detailed price information for Thermo Fisher Scientific (TMO-N) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.